135 related articles for article (PubMed ID: 17205522)
1. Low adiponectin levels are associated with renal cell carcinoma: a case-control study.
Spyridopoulos TN; Petridou ET; Skalkidou A; Dessypris N; Chrousos GP; Mantzoros CS;
Int J Cancer; 2007 Apr; 120(7):1573-8. PubMed ID: 17205522
[TBL] [Abstract][Full Text] [Related]
2. Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trial.
Liao LM; Hofmann JN; Cho E; Pollak MN; Chow WH; Purdue MP
Cancer Causes Control; 2017 Jul; 28(7):801-807. PubMed ID: 28484923
[TBL] [Abstract][Full Text] [Related]
3. Inverse association of leptin levels with renal cell carcinoma: results from a case-control study.
Spyridopoulos TN; Petridou ET; Dessypris N; Terzidis A; Skalkidou A; Deliveliotis C; Chrousos GP;
Hormones (Athens); 2009; 8(1):39-46. PubMed ID: 19278051
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of adipocytokine omentin-1 in patients with renal cell cancer.
Shen XD; Zhang L; Che H; Zhang YY; Yang C; Zhou J; Liang CZ
Cytokine; 2016 Jan; 77():50-5. PubMed ID: 26539805
[TBL] [Abstract][Full Text] [Related]
5. Prediagnostic circulating adipokine concentrations and risk of renal cell carcinoma in male smokers.
Liao LM; Weinstein SJ; Pollak M; Li Z; Virtamo J; Albanes D; Chow WH; Purdue MP
Carcinogenesis; 2013 Jan; 34(1):109-12. PubMed ID: 23042303
[TBL] [Abstract][Full Text] [Related]
6. Decreased serum adiponectin levels in patients with metastatic renal cell carcinoma.
Horiguchi A; Ito K; Sumitomo M; Kimura F; Asano T; Hayakawa M
Jpn J Clin Oncol; 2008 Feb; 38(2):106-11. PubMed ID: 18245516
[TBL] [Abstract][Full Text] [Related]
7. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study.
Wei EK; Giovannucci E; Fuchs CS; Willett WC; Mantzoros CS
J Natl Cancer Inst; 2005 Nov; 97(22):1688-94. PubMed ID: 16288122
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance and risk of renal cell cancer: a case-control study.
Spyridopoulos TN; Dessypris N; Antoniadis AG; Gialamas S; Antonopoulos CN; Katsifoti K; Adami HO; Chrousos GP; Petridou ET;
Hormones (Athens); 2012; 11(3):308-15. PubMed ID: 22908063
[TBL] [Abstract][Full Text] [Related]
9. Obesity and Kidney Cancer.
Wilson KM; Cho E
Recent Results Cancer Res; 2016; 208():81-93. PubMed ID: 27909903
[TBL] [Abstract][Full Text] [Related]
10. Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear-cell carcinoma of the kidney.
Pinthus JH; Kleinmann N; Tisdale B; Chatterjee S; Lu JP; Gillis A; Hamlet T; Singh G; Farrokhyar F; Kapoor A
Eur Urol; 2008 Oct; 54(4):866-73. PubMed ID: 18343565
[TBL] [Abstract][Full Text] [Related]
11. Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome.
Dalamaga M; Karmaniolas K; Chamberland J; Nikolaidou A; Lekka A; Dionyssiou-Asteriou A; Mantzoros CS
Metabolism; 2013 Dec; 62(12):1830-9. PubMed ID: 24140093
[TBL] [Abstract][Full Text] [Related]
12. Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies.
Petridou ET; Mitsiades N; Gialamas S; Angelopoulos M; Skalkidou A; Dessypris N; Hsi A; Lazaris N; Polyzos A; Syrigos C; Brennan AM; Tseleni-Balafouta S; Mantzoros CS
Oncology; 2007; 73(3-4):261-9. PubMed ID: 18424891
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin gene polymorphisms and obesity increase the susceptibility to arsenic-related renal cell carcinoma.
Hsueh YM; Chen WJ; Lin YC; Huang CY; Shiue HS; Yang SM; Ao PL; Pu YS; Su CT
Toxicol Appl Pharmacol; 2018 Jul; 350():11-20. PubMed ID: 29723618
[TBL] [Abstract][Full Text] [Related]
14. Circulating adiponectin as a biomarker in renal cell carcinoma: a systematic review and meta-analysis.
Yap NY; Yap FN; Perumal K; Rajandram R
Biomarkers; 2019 Sep; 24(6):607-614. PubMed ID: 31215811
[No Abstract] [Full Text] [Related]
15. Serum leptin and adiponectin levels and risk of renal cell carcinoma.
Liao LM; Schwartz K; Pollak M; Graubard BI; Li Z; Ruterbusch J; Rothman N; Davis F; Wacholder S; Colt J; Chow WH; Purdue MP
Obesity (Silver Spring); 2013 Jul; 21(7):1478-85. PubMed ID: 23666639
[TBL] [Abstract][Full Text] [Related]
16. Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study.
Dalamaga M; Karmaniolas K; Panagiotou A; Hsi A; Chamberland J; Dimas C; Lekka A; Mantzoros CS
Cancer Causes Control; 2009 Mar; 20(2):193-9. PubMed ID: 18814045
[TBL] [Abstract][Full Text] [Related]
17. Circulating adiponectin levels in relation to melanoma: a case-control study.
Mantzoros CS; Trakatelli M; Gogas H; Dessypris N; Stratigos A; Chrousos GP; Petridou ET
Eur J Cancer; 2007 Jun; 43(9):1430-6. PubMed ID: 17512191
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) system.
Dalamaga M; Karmaniolas K; Nikolaidou A; Chamberland J; Hsi A; Dionyssiou-Asteriou A; Mantzoros CS
Eur J Cancer; 2008 Aug; 44(12):1744-53. PubMed ID: 18515085
[TBL] [Abstract][Full Text] [Related]
19. Macronutrients, fatty acids, cholesterol and renal cell cancer risk.
Bidoli E; Talamini R; Zucchetto A; Polesel J; Bosetti C; Negri E; Maruzzi D; Montella M; Franceschi S; La Vecchia C
Int J Cancer; 2008 Jun; 122(11):2586-9. PubMed ID: 18224688
[TBL] [Abstract][Full Text] [Related]
20. Renal cell cancer and body size at different ages: an Italian multicenter case-control study.
Dal Maso L; Zucchetto A; Tavani A; Montella M; Ramazzotti V; Talamini R; Canzonieri V; Garbeglio A; Negri E; Tonini A; La Vecchia C; Franceschi S
Am J Epidemiol; 2007 Sep; 166(5):582-91. PubMed ID: 17591592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
